Literature DB >> 30488082

Midnight salivary cortisol for the diagnosis of Cushing's syndrome in a Chinese population.

Dao-Chen Lin1,2, Pei-Shan Tsai3,4,5, Yi-Chun Lin2,6.   

Abstract

INTRODUCTION: Cushing's syndrome is defined as chronic excess free cortisol in circulation. According to recent studies, midnight salivary cortisol is an accurate and non-stress method for screening and diagnosing Cushing's syndrome. However, there is limited data on midnight salivary cortisol for diagnosing Cushing's syndrome in the Chinese population.
METHODS: Among 61 suspected Chinese patients, 48 patients were confirmed to have Cushing's syndrome. We evaluated the midnight salivary cortisol, midnight serum cortisol and 24-hour urine free cortisol excretion for diagnosis. Midnight salivary cortisol was collected from 21 healthy volunteers for control purposes.
RESULTS: In the patient group, mean urine free cortisol excretion and midnight salivary cortisol levels were 296.50 ± 47.99 µg/day and 10.18 ± 1.29 ng/mL, respectively. Among the control group and normal participants, mean midnight salivary cortisol level was 0.53 ± 0.13 ng/mL and 0.50 ± 0.12 ng/mL, respectively. The cut-off value for midnight salivary cortisol was 1.7 ng/mL for diagnosing Cushing's syndrome, with a sensitivity of 98% and specificity of 100%. The diagnostic performance of midnight salivary cortisol (area under the curve [AUC] = 0.99) was superior to that of urine free cortisol (AUC = 0.89).
CONCLUSION: Our study confirmed the good diagnostic performance of midnight salivary cortisol for diagnosing Cushing's syndrome in a Chinese population. Correlation between midnight salivary cortisol and either urine free cortisol or midnight serum cortisol was good. Midnight salivary cortisol is a convenient and precise tool for diagnosing Cushing's syndrome and can be the screening test of choice for Chinese populations. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  Cushing’s disease; Cushing’s syndrome; midnight salivary cortisol; midnight serum cortisol; urine free cortisol

Mesh:

Substances:

Year:  2018        PMID: 30488082      PMCID: PMC6658651          DOI: 10.11622/smedj.2018154

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  30 in total

1.  Out-patient screening for Cushing's syndrome: the sensitivity of the combination of circadian rhythm and overnight dexamethasone suppression salivary cortisol tests.

Authors:  M Castro; P C Elias; A R Quidute; F P Halah; A C Moreira
Journal:  J Clin Endocrinol Metab       Date:  1999-03       Impact factor: 5.958

2.  Incidence and late prognosis of cushing's syndrome: a population-based study.

Authors:  J Lindholm; S Juul; J O Jørgensen; J Astrup; P Bjerre; U Feldt-Rasmussen; C Hagen; J Jørgensen; M Kosteljanetz; L Kristensen; P Laurberg; K Schmidt; J Weeke
Journal:  J Clin Endocrinol Metab       Date:  2001-01       Impact factor: 5.958

3.  Nighttime salivary cortisol measurement as a simple, noninvasive, outpatient screening test for Cushing's syndrome in children and adolescents.

Authors:  R I Gafni; D A Papanicolaou; L K Nieman
Journal:  J Pediatr       Date:  2000-07       Impact factor: 4.406

4.  Salivary cortisol measurement--a reliable method for the diagnosis of Cushing's syndrome.

Authors:  M Trilck; J Flitsch; D K Lüdecke; R Jung; S Petersenn
Journal:  Exp Clin Endocrinol Diabetes       Date:  2005-04       Impact factor: 2.949

5.  Salivary cortisol for screening of Cushing's syndrome in children.

Authors:  C E Martinelli; S L Sader; E B Oliveira; J C Daneluzzi; A C Moreira
Journal:  Clin Endocrinol (Oxf)       Date:  1999-07       Impact factor: 3.478

6.  Midnight salivary cortisol versus urinary free and midnight serum cortisol as screening tests for Cushing's syndrome.

Authors:  Pietro Putignano; Paola Toja; Antonella Dubini; Francesca Pecori Giraldi; Salvatore Maria Corsello; Francesco Cavagnini
Journal:  J Clin Endocrinol Metab       Date:  2003-09       Impact factor: 5.958

7.  Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan.

Authors:  Masao Omura; Jun Saito; Kunio Yamaguchi; Yukio Kakuta; Tetsuo Nishikawa
Journal:  Hypertens Res       Date:  2004-03       Impact factor: 3.872

8.  Midnight salivary cortisol for the initial diagnosis of Cushing's syndrome of various causes.

Authors:  Maria Yaneva; Helen Mosnier-Pudar; Marie-Annick Dugué; Sophie Grabar; Yvonne Fulla; Xavier Bertagna
Journal:  J Clin Endocrinol Metab       Date:  2004-07       Impact factor: 5.958

9.  Occult Cushing's syndrome in type-2 diabetes.

Authors:  Bogdan Catargi; Vincent Rigalleau; Agathe Poussin; Nathalie Ronci-Chaix; Veronique Bex; Vincent Vergnot; Henri Gin; Patrick Roger; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2003-12       Impact factor: 5.958

10.  Nighttime salivary cortisol: a useful test for the diagnosis of Cushing's syndrome.

Authors:  Dimitris A Papanicolaou; Nancy Mullen; Ioannis Kyrou; Lynnette K Nieman
Journal:  J Clin Endocrinol Metab       Date:  2002-10       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.